Zeolite treatment of cancers in test animals and humans
Preliminary research was conducted at the Ruder Boskovic Institute in Croatia with the aim of establishing conditions for carrying out clinical testing of zeolite. Investigation was carried out on the effects of zeolite on human tumor cells in vitro and on the the growth of melanoman tumors in mice in vivo, as well as in cases of complication with diabetes mellitus.
In vitro, tests were run on the influence of zeolite on the inhibition of growth in human pancreatic carcinoma, cervical carcinoma and laryngeal carcinoma. Results showed that inhibition of cells growth occurred dependant on the dosage used of zeolite (in powdered form) and the type of tumor.
In vivo, laboratory mice were inoculated with melanoma cells and were given zeolite(powder) twice a day orally for five days. Observation of tumor volume confirmed that zeolite reduced tumor volume in mice.
Testing was also carried out on five male patients, in the United States, between the ages of 51 and 69 suffering from: prostate cancer, liver cancer, Crohn’s disease, intestinal cancer and lung cancer. All patients had a signicant improvement in overall condition, increased body weight, as well as disappearance of symptoms.
Dr Kresimir Pavelic, PHD., Ruder Boskovic Institute,
Dept. of Molecular Medicine, Croatia, March, 1998